$CBIS Up to date company activities and other important

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
$CBIS Up to date company activities and other important information about $CBIS

$CBIS

DD Notes ~ http://www.ddnotesmaker.com/CBIS

##### recent news/filings ~ source: finance.yahoo.com

Fri, 10 Jan 2014 13:04:28 GMT ~ A Smokey Bubble On The Horizon
- (Editors' Note: This article covers micro-cap stocks. Please be aware of the risks associated with these stocks.) I was thinking of starting this article out by quoting Jimi Hendrix "Purple Haze", ...
read full: http://seekingalpha.com/article/1938411-a-smo...urce=yahoo
*********************************************************

Thu, 02 Jan 2014 18:15:46 GMT ~ Up in Smoke: Marijuana Stocks Fly High as Colorado Law Takes Effect
- Shares of volatile marijuana stocks like Medbox soared following the launch of legalized recreational pot use in Colorado.
read full: http://www.foxbusiness.com/investing/2014/01/...es-effect/
*********************************************************

Mon, 02 Dec 2013 18:56:00 GMT ~ Cannabis Science (CBIS) Moves Forward with Critical Support of Landmark Federal Cannabis Legislative Initiative
- COLORADO SPRINGS, Colo., Dec. 2, 2013 /PRNewswire/ -- (NASDAQ OTC: CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development, is a key leader in the private sector challenge to end the restrictions on cannabis drug development and research in the U.S. "The Cannabinoid Scientific Research and Development Act," which will be submitted for congressional review in the U.S. Senate and House of Representatives by the end of January 2014, is landmark legislation seeking equal treatment for cannabinoid scientific research. In addition, the legislation aims to provide the framework for the clinical investigation of the hundreds of strains of cannabis and their constituent cannabinoids regarding their medical efficacy on a wide range of life-threatening, chronic, and infectious diseases. The legislation also seeks to provide "an informed clinical environment for physicians, researchers and consumers to make effective clinical choices regarding their therapeutic treatments for a variety of diseases," said Dr. Robert Melamede, President, Cannabis Science. "We need rational federal standards based upon science to replace inadequate public policies rooted in the misperceptions of the past," Dr. Melamede added.
read full: http://finance.yahoo.com/news/cannabis-scienc...00113.html
*********************************************************

Wed, 27 Nov 2013 18:04:11 GMT ~ CANNABIS SCIENCE, INC. Financials
read full: http://finance.yahoo.com/q/is?s=cbis
*********************************************************

Mon, 25 Nov 2013 19:29:00 GMT ~ Cannabis Science Working With cannabis caucus in the U.S. House of Representatives in the Fight to Level the Playing Field for Cannabis Drug Research and Development
- COLORADO SPRINGS, Colo., Nov. 25, 2013 /PRNewswire/ -- (NASDAQ OTC: CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development, is working with the the cannabis caucus in the U.S. House of Representatives to initiate substantial changes in 2014 in the way cannabis research and drug development can be done in this country. Working with leading exponents of cannabis drug research and development and a bi-partisan coalition in Congress, CBIS has drafted legislation as the template for these ground-breaking changes and is working with other interested parties for its passage early next year. "We expect ground breaking changes in 2014 in our ability to conduct clinically-related drug research with cannabinoids," said Dr. Robert Melamede, president, Cannabis Science. "We will have a definitively clearer pathway for much needed clinical research on cannabinoids next year that will allow us to determine the clinical affect of dozens of different strains of cannabis for chronic and infectious disease," Dr. Melamede said.
read full: http://finance.yahoo.com/news/cannabis-scienc...00363.html
*********************************************************

##### chart ~ source: stockcharts.com

stockcharts.com/c-sc/sc?s=CBIS&p=D&b=5&g=0&id=p95448242713

##### chart ~ source: eoddata.com

http://chart.eoddata.com/?e=OTCBB&s=CBIS&...D&b=BB

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/CBIS/company-info
Ticker: $CBIS
OTC Market Place: OTCQB
CIK code: 0001024626
Company name: Cannabis Science, Inc.
Company website: http://www.cannabisscience.com
Incorporated In: NV, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/CBIS/filings
Latest financials: http://www.otcmarkets.com/stock/CBIS/financials
Latest news: http://www.otcmarkets.com/stock/CBIS/news - http://finance.yahoo.com/q/h?s=CBIS+Headlines

Major holdings: http://data.cnbc.com/quotes/CBIS/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=CBIS+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/CBIS.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=CBIS

RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search

DTCC: http://search2.dtcc.com/?q=Cannabis+Science%2...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...nce%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.cannabisscience.com
Alexa: http://www.alexa.com/siteinfo/http://www.cann...ience.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.cannabisscience.com

http://www.pennystocktweets.com/stocks/profile/CBIS

##### last known share structure ~ source: otcmarkets.com

Market Value: $111,914,614 a/o Jan 09, 2014
Shares Outstanding: 761,323,906 a/o Nov 18, 2013
Float: 24,000,000 a/o Jun 17, 2010
Authorized Shares: 250,000,000 a/o Jun 17, 2010
Par Value: 0.001

##### business description ~ source: otcmarkets.com

Research & Development of medical cannabis compounds

DD Notes ~ http://www.ddnotesmaker.com/CBIS

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Navigating Land Access: The Hidden Roadblock in Mining

Updated Category News Views 3

Mining's Often Overlooked Obstacle: Land Access In the world of mining, the shallow thrills of striking gold are often overshadowed by the frustrating slog of securing land access. You can have your permits lined up, your finances sorted, and drills humming along, but if you haven’t sweet-talked the folks farming above your visible vein of riches, you could be staring...

Continue Reading
GBI Bio's New CEO Jesse McCool to Propel Growth

Updated Category News Views 4

Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...

Continue Reading
AI Trust in Finance: Survey Reveals Market Impact

Updated Category News Views 3

Trust in AI for Financial Guidance: Where Are We Headed? The market winds shift with every sunrise, and today’s buzzword? Artificial Intelligence. You’d almost think AI’s trying to steal my job along with every other trader’s mojo. But here's the twist—A survey from Possible Finance shows about 15% of folks would actually lean on AI for their financial advice....

Continue Reading
SES Sells to AFC Industries: A Strategic M&A Move

Updated Category News Views 1

Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...

Continue Reading
Atli Launches: AI-Powered eSIM Revolutionizes Travel

Updated Category News Views 5

What's New in Travel Tech: Atli's Debut Wandering the globe might sound romantic until you realize your phone's a paperweight without the right data. Enter Atli, a shiny new AI-powered travel eSIM service, snugged right into your WhatsApp. This marvel comes from the folks at XForge Mobile and aims to obliterate the hassle of getting connected abroad. You know those...

Continue Reading
World Fire Congress 2026 Champions Global Fire Safety

Updated Category News Views 1

Rethinking Fire Safety with a Global Mindset The 2026 World Fire Congress wrapped up in London, signaling a big shift in how we tackle fire safety. Over 60 nations were represented, and they all walked away singing the same tune: if we’re going to handle these ever-mounting fire risks, we have to lean on each other a lot more. Next stop on this crusade? The flashy city...

Continue Reading
Insurance Bad Faith: Navigating California's Rigorous Laws

Updated Category News Views 4

Understanding What Constitutes Bad Faith Insurance What does it really mean when an insurer acts in "bad faith"? Well, the legal standard doesn't leave much wiggle room in California. These aren't just bad outcomes; we're talking about conduct that defies what's reasonable under state law. Demián I. Oksenendler, a seasoned bad faith attorney, shed some light on this in a...

Continue Reading
Moore Law Investigates Aardvark Therapeutics' Risks

Updated Category News Views 2

Moore Law Launches Probe Into Aardvark Therapeutics Nobody likes stumbling across bad news over their morning coffee, but sometimes the market loves to keep you on your toes. Now it's Aardvark Therapeutics (NASDAQ: AARD) in the headlines, and not how they'd like. This time, Moore Law PLLC is rolling up its sleeves to dig into potential misconduct by the company's top...

Continue Reading
RealNex Navigator Upgrades Unveil Vast CRE Capabilities

Updated Category News Views 4

The Dawn of a New Navigator for CRE RealNex is unleashing a storm of enhancements to its Navigator platform, shaking up the commercial real estate (CRE) scene. Their latest upgrades are setting a new precedent for how brokers use technology to sharpen their game, handle transactions, and strategize in a market that never sleeps. Diving Deep into the Latest Upgrades First...

Continue Reading
Merit Advisors Shines as Top Energy Workplace

Updated Category News Views 1

Well, here's something to chew on—Merit Advisors just grabbed the top spot on Hart Energy's first-ever Best Places to Work in Energy list. If you haven't heard of them, Merit's the heavyweight champ in specialty tax for the energy sector. This isn't just a shiny trophy on the shelf; it's a nod to the kind of culture that's making waves in an industry that's no stranger...

Continue Reading

Top 5 Most Recently Viewed Articles

Intel Soars As Potential Government Stake Sparks Optimism

Updated Category News Views 180

Intel Sees Unprecedented Stock Surge Intel Corp. (NASDAQ: INTC) is experiencing remarkable growth in its stock performance, achieving its most impressive week in over two decades. The driving force behind this impressive surge stems from strong political backing, particularly from the former President. This support has energized market enthusiasm as investors speculate on...

Continue Reading
Class Action Filed for Transocean Ltd. (RIG) Investors

Updated Category News Views 165

Understanding the Class Action Lawsuit for Transocean Ltd. Investors Transocean Ltd. is currently facing a class action lawsuit that has garnered significant attention among its investors. This situation arises as the company strives to manage its asset portfolio and navigate the complexities of its business model. What Led to the Class Action Filing? The Law Offices of...

Continue Reading
Biohaven Unveils 2024 Financial Performance and Innovations

Updated Category News Views 297

Overview of Biohaven Ltd.'s Recent Developments Biohaven Ltd. (NYSE: BHVN), a biopharmaceutical company, has made remarkable strides in its drug development and therapeutic pipeline. Recently, the company announced significant updates on its product advancements, particularly focusing on its innovation in therapeutic platforms. Biohaven's recent developments highlight...

Continue Reading
Revolutionary Treatment Shows Promise for Cancer-Related Skin Issues

Updated Category News Views 36

Innovative Treatment for Skin Toxicities in Cancer Patients Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on creating innovative solutions for unmet medical needs, has reached an important milestone with its new therapy, HT-001. This innovative treatment specifically targets skin toxicities associated with epidermal growth factor receptor...

Continue Reading
AMG Reports Exceptional Financial Growth for Q1 2025

Updated Category News Views 237

AMG Sees Significant Growth in First Quarter Results AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) has announced impressive financial results for the first quarter of 2025, marking a substantial growth compared to the previous year. With a revenue of $388 million, this reflects an 8% increase from $358 million in the same period last year....

Continue Reading